Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$483.07 - $625.6 $3.15 Million - $4.08 Million
6,520 Added 40.39%
22,662 $11.9 Million
Q1 2025

May 15, 2025

BUY
$634.14 - $744.83 $8.25 Million - $9.69 Million
13,010 Added 415.39%
16,142 $10.2 Million
Q4 2024

Feb 14, 2025

BUY
$701.85 - $1046.91 $2.2 Million - $3.28 Million
3,132 New
3,132 $2.23 Billion

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Jain Global LLC Portfolio

Follow Jain Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.